Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Kirby McInerney LLP : Announces That a Securities Class Action Lawsuit Has Been Filed Against Health Insurance Innovations, Inc. (HIIQ)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2017 | 07:39pm CEST

Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities that acquired Health Insurance Innovations, Inc. (HIIQ) securities during the period from August 2, 2017 through September 11, 2017 (the “Class Period”). The suit asserts claims for violation of the federal securities laws against Health Insurance Innovations, Inc. (the “Company”) and several of its senior officers. Pursuant to applicable law, investors have until November 10, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The lawsuit alleges that during the Class Period, defendants failed to disclose that the Company had been denied a key insurance license in Florida due in part to material errors and omissions in the Company’s application. Following a September 11, 2017 public report of this licensing rejection, the Company’s share price fell from $29.90 to $23.35, a decline of $6.55 per share.

If you acquired Health Insurance Innovations, Inc. securities during the Class Period, have information about this matter, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Sarah Lynch by email at [email protected], or telephone at (212) 371-6600, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, whistleblower, antitrust and consumer litigation. Kirby McInerney’s efforts on behalf of shareholders have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: www.kmllp.com.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
09/23 Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in He..
09/22 ROBBINS ARROYO LLP : Health Insurance Innovations, Inc. (HIIQ) Misled Shareholde..
09/22 GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of Health Insura..
09/21 HEALTH INSURANCE INNOVATIONS : Kirby McInerney LLP Announces That a Securities C..
09/21 HEALTH INSURANCE INNOVATIONS : Glancy Prongay & Murray LLP Commences Investigati..
09/21 HEALTH INSURANCE INNOVATIONS LEAD PL : Faruqi & Faruqi, LLP Encourages Investors..
09/21 Investigation of Health Insurance Innovations Announced by Holzer & Holzer
09/20 Levi & Korsinsky, LLP Notifies Shareholders of Health Insurance Innovations, ..
09/20 HEALTH INSURANCE INNOVATIONS INC : Pomerantz Law Firm Reminds Shareholders with ..
09/19 Khang & Khang LLP Announces a Securities Class Action Lawsuit against Health ..
More news
News from SeekingAlpha
09/12 Midday Gainers / Losers
09/12 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/12 Lake Street says bearish SA article a "rehash" of old news, recommends aggres..
09/12 PREMARKET LOSERS AS OF 9 : 05 am
09/11 HEALTH INSURANCE INNOVATIONS TO HOST : 30 pm ET
Financials ($)
Sales 2017 230 M
EBIT 2017 34,5 M
Net income 2017 19,2 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 13,88
P/E ratio 2018 11,51
Capi. / Sales 2017 1,55x
Capi. / Sales 2018 1,35x
Capitalization 358 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 38,7 $
Spread / Average Target 78%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President & Chief Executive Officer
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger Chief Financial Officer, Secretary & Treasurer
Sheldon X. Wang Chief Technology Officer
Michael W. Kosloske Director & Chief-Product Innovation
Sector and Competitors